Babraham Research Campus — Bennet Building (Credit: Riba Architecture)
March 13, 2024 09:31 AM EDTUpdated 01:59 PM
People
R&D

Sanofi to shut­ter ex-Kymab R&D fa­cil­i­ty in the UK

Anna Brown

News Reporter

Sanofi is clos­ing an ex-Kymab re­search and de­vel­op­ment site in Cam­bridge, UK, which could see job loss­es for 90 staffers, a com­pa­ny spokesper­son told …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

The End­points 2024 win­ners and losers list: Who was up and who was down in bio­phar­ma

Up­dat­ed: No­vo’s 23% weight loss with Ca­griSe­ma falls short of high ex­pec­ta­tions, new tri­al planned

FDA ap­proves Hu­ma­cyte’s lab-grown blood ves­sels in mile­stone for re­gen­er­a­tive med­i­cine

Ac­cel­er­at­ed ap­proval brings Pfiz­er's BRAF in­hibitor to first-line pa­tients

Ex­clu­sive: Flori­da can­cer biotech rais­es $100M Se­ries A

Sofinno­va out­lines $550M fund af­ter IPOs and M&A deals

A service from the Financial Times